Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI

PURPOSE: Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy is the routine treatment for patients with metastatic non-small cell lung cancer (NSCLC) harboring positive EGFR mutations. Patients who undergo such treatment have reported cognitive decline during follow-up. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Beisheng, Luo, Chunli, Yu, Min, Zhou, Lin, Tao, Bo, Tang, Biqiu, Zhou, Ying, Zhu, Jiang, Huang, Meijuan, Peng, Feng, Liu, Yongmei, Xu, Yong, Zhang, Yan, Zhou, Xiaojuan, Xue, Jianxin, Li, Yanying, Wang, Yongsheng, Li, Zhiping, Lu, You, Lui, Su, Gong, Youling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815525/
https://www.ncbi.nlm.nih.gov/pubmed/33489880
http://dx.doi.org/10.3389/fonc.2020.573512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815525/
https://www.ncbi.nlm.nih.gov/pubmed/33489880
http://dx.doi.org/10.3389/fonc.2020.573512

Ejemplares similares